These data together suggest that proteins associated with deregulated mitophagy/autophagy, insulin signaling, and glycolysis/gluconeogenesis pathways could be potential platelet biomarkers for cognitive decline in T2DM patients. The gene discussed is INS; the disease is type 2 diabetes mellitus.